Analysts Set Lakeland Industries, Inc. (NASDAQ:LAKE) PT at $16.00

Shares of Lakeland Industries, Inc. (NASDAQ:LAKE) have received a consensus recommendation of “Hold” from the five brokerages that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $16.00.

Several research analysts have recently weighed in on the stock. Lake Street Capital decreased their price objective on shares of Lakeland Industries from $16.00 to $13.00 and set a “buy” rating for the company in a report on Friday, April 17th. Maxim Group set a $16.00 target price on shares of Lakeland Industries in a research report on Monday, April 20th. Weiss Ratings upgraded shares of Lakeland Industries from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, June 29th. Wall Street Zen cut Lakeland Industries from a “hold” rating to a “sell” rating in a report on Saturday, June 27th. Finally, DA Davidson raised their price target on Lakeland Industries from $14.00 to $18.00 and gave the stock a “buy” rating in a research note on Thursday, June 11th.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of LAKE. BNP Paribas Financial Markets grew its stake in shares of Lakeland Industries by 87.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,795 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 839 shares during the period. First Trust Advisors LP lifted its stake in shares of Lakeland Industries by 4.2% in the 2nd quarter. First Trust Advisors LP now owns 28,554 shares of the medical instruments supplier’s stock worth $389,000 after purchasing an additional 1,149 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of Lakeland Industries by 2.0% in the first quarter. Bank of New York Mellon Corp now owns 75,107 shares of the medical instruments supplier’s stock worth $615,000 after buying an additional 1,479 shares during the last quarter. Rhumbline Advisers grew its position in Lakeland Industries by 16.0% during the third quarter. Rhumbline Advisers now owns 13,415 shares of the medical instruments supplier’s stock valued at $199,000 after buying an additional 1,853 shares during the period. Finally, Wells Fargo & Company MN grew its position in Lakeland Industries by 35.5% during the fourth quarter. Wells Fargo & Company MN now owns 9,514 shares of the medical instruments supplier’s stock valued at $84,000 after buying an additional 2,492 shares during the period. Institutional investors own 71.69% of the company’s stock.

Lakeland Industries Price Performance

NASDAQ LAKE opened at $11.10 on Friday. Lakeland Industries has a one year low of $7.15 and a one year high of $18.00. The stock has a 50-day moving average of $10.54 and a 200 day moving average of $9.61. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.34 and a current ratio of 3.09. The company has a market capitalization of $109.56 million, a price-to-earnings ratio of -5.21 and a beta of 1.45.

Lakeland Industries (NASDAQ:LAKE) last posted its earnings results on Tuesday, June 9th. The medical instruments supplier reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.18. The business had revenue of $47.42 million for the quarter, compared to analysts’ expectations of $47.36 million. Lakeland Industries had a negative net margin of 10.87% and a negative return on equity of 6.64%. On average, sell-side analysts forecast that Lakeland Industries will post -0.28 EPS for the current year.

Lakeland Industries Company Profile

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.